Related Experiment Video
Updated: May 2, 2026

09:57
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
8.3K
pH-responsive robust polymer micelles with metal-ligand coordinated core cross-links
Gyu Ha Hwang1, Kyung Hyun Min, Hong Jae Lee
1Department of Life and Nanopharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 130-701, Korea.
Summary
Researchers developed pH-responsive polymer micelles with unique cross-links. These micelles enhance anticancer drug delivery by releasing medication in acidic tumor environments.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Nanotechnology
Background:
- Polymer micelles are promising drug delivery vehicles.
- Achieving controlled drug release in specific cellular environments remains a challenge.
- Endosomal acidification is a key trigger for intracellular drug release.
Purpose of the Study:
- To engineer pH-responsive core-shell polymer micelles.
- To incorporate catechol-Fe(3+) coordinated cross-links for enhanced micelle stability.
- To facilitate the intracellular release of anticancer drugs in response to acidic pH.
Main Methods:
- Synthesis of core-shell polymer micelles.
- Incorporation of catechol-Fe(3+) coordination for cross-linking.
- Evaluation of pH-responsiveness and drug release kinetics.
- Assessment of micelle stability under physiological and endosomal conditions.
Main Results:
- Successfully fabricated robust, pH-responsive core-shell polymer micelles.
- Catechol-Fe(3+) cross-links provided structural integrity to the micelles.
- Demonstrated facilitated intracellular drug release at acidic pH mimicking endosomal conditions.
- Enhanced drug loading and stability compared to non-cross-linked micelles.
Conclusions:
- pH-responsive polymer micelles with catechol-Fe(3+) cross-links are effective for targeted anticancer drug delivery.
- The developed system offers improved micelle robustness and controlled drug release.
- This platform holds potential for enhanced cancer therapy by leveraging endosomal pH changes.

